All Issue

2020 Vol.50, Issue 2

Review Article

Strength and Weakness of Molecular Identification Strategies Against Causative Viral Agent from Emerging COVID-19
Chunguang Cui1
,
Kisoon Kim1*
1Department of Microbiology, Institute for Viral Diseases, College of Medicine, Korea University, 73, Goryeodae-ro, Seongbuk-gu, Seoul 02841,Republic of Korea
*Corresponding Author
30 June 2020. pp. 65-75
PDF XML Citation
Abstract

A century ago, more exactly 102 years ago, there was a devastating pandemic of influenza in 1918 and thereafter, periodic recurrences of pandemic events have been reported in the human population. Unfortunately, whenever it happened, the outcome was concomitant with over millions of death tolls due to considerably higher case fatality rates, compared to other infectious diseases at that time. In this regard, pandemics, which continued at irregular time intervals, give a great significance to global public health responses. However, it is far from feasibility to predict when a next pandemic will begin and how much disease burden will be despite our efforts to utilize all kinds of available scientific information and knowledge. The one clear thing is that approximately 70% of the causative agents of emerging and/or re-emerging diseases including COVID-19 (coronavirus disease 2019), which has been started from Wuhan province, China in December 2019 and has resulted in more than 4 million human cases within a few months, are viruses. Therefore, it is very important to secure fast and accurate identification methods of a causative pathogen in order to provide scientific clues and to prepare in advance for the abrupt occurrence of unknown viral diseases in a timely manner. In this review, the current status and future perspectives of the molecular technology for identification of viral pathogens such as SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) with regard to rapid public health responses in the early stage of infectious diseases including COVID-19, will be discussed.

Keywords
COVID-19
Molecular diagnosis
Pandemic
qRT-PCR
SARS-CoV-2
References
1
WORLDOMETER https://www.worldometers.info/coronavirus/
2
Korea Centers for Disease Control and Prevention (KCDC). The updates on COVID-19 in Korea as of 14 June.
3
Amanat F, Krammer F. SARS-CoV-2 Vaccines: Status Report. Immunity 2020; 52:583-9.
10.1016/j.immuni.2020.03.00732259480PMC7136867
4
Li H, Zhou Y, Zhang M, Wang H, Zhao Q, Liu J. Updated Approaches against SARS-CoV-2. Antimicrob Agents Chemother 2020;64:e00483-20.
10.1128/AAC.00483-2032205349PMC7269512
5
Hunter P. Viral vigilance. New surveillance strategies and methods help to identify dangerous pathogens earlier: a prerequisite for efficient countermeasures. EMBO 2008;9:948-50.
10.1038/embor.2008.18118830223PMC2572123
6
Zhang N, Li C, Hu Y, Li K, Liang J, Wang L, et al. Current development of COVID-19 diagnostics, vaccines and therapeutics. Microbes Infect 2020;S1286-4579(20)30079-4.
10.1016/j.micinf.2020.05.001
7
Ahn DG, Shin HJ, Kim MH, Lee S, Kim HS, Myoung J, et al. Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19). J Microbiol Biotechnol 2020;30:313-24.
10.4014/jmb.2003.0301132238757
8
Tu YF, Chien CS, Yarmishyn AA, Lin YY, Luo YH, Lin YT, et al. A Review of SARS-CoV-2 and the Ongoing Clinical Trials. Int J Mol Sci 2020;21:2657.
10.3390/ijms2107265732290293PMC7177898
9
Ciliberto G, Mancini R, Paggi MG. Drug repurposing against COVID-19: focus on anticancer agents. J Exp Clin Cancer Res 2020;39:86.
10.1186/s13046-020-01590-232398164PMC7214852
10
Ma C, Su S, Wang J, Wei L, Du L, Jiang S. From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development. Microbes Infect 2020:S1286-4579(20)30082-4.
10.1016/j.micinf.2020.05.004
11
Prompetchara E, Ketloy C, Palaga T. Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol 2020;38:1-9.
12
de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol 2016;14:523-34.
10.1038/nrmicro.2016.8127344959PMC7097822
13
Liu J, Zheng X, Tong Q, Li W, Wang B, Sutter K, et al. Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. J Med Virol 2020;92:491-4.
10.1002/jmv.2570932056249PMC7166760
14
Neumann G, Noda T, Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 2009;459:931-9.
10.1038/nature0815719525932PMC2873852
15
Hematian A, Sadeghifard N, Mohebi R, Taherikalani M, Nasrolahi A, Amraei M, et al. Traditional and Modern Cell Culture in Virus Diagnosis. Osong Public Health Res Perspect 2016;7:77-82.
10.1016/j.phrp.2015.11.01127169004PMC4850366
16
Leland DS, Ginocchio CC. Role of cell culture for virus detection in the age of technology. Clin Microbiol Rev 2007;20:49-78.
10.1128/CMR.00002-0617223623PMC1797634
17
Matsuyama S, Nao N, Shirato K, Kawase M, Saito S, Takayama I. et al., Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proc Natl Acad Sci U S A 2020;117:7001-3.
10.1073/pnas.200258911732165541PMC7132130
18
Ma D, Chen CB, Jhanji V, Xu C, Yuan XL, Liang JJ, et al. Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea. Eye (Lond) 2020:1-8.
10.1038/s41433-020-0939-432382146PMC7205026
19
Guo Y, Tisoncik J, McReynolds S, Farzan M, Prabhakar BS, Gallagher T, et al. Identification of a new region of SARS-CoV S protein critical for viral entry. J Mol Biol 2009;394:600-5.
10.1016/j.jmb.2009.10.03219853613PMC2794126
20
Leland DS, Ginocchio CC. Role of Cell Culture for Virus Detection in the Age of Technology. Clin Microbiol Rev 2007;20:49-78.
10.1128/CMR.00002-0617223623PMC1797634
21
Fernandez-Garcia MD, Simon-Loriere E, Kebe O, Sakuntabhai A, Ndiaye K. Identification and molecular characterization of the first complete genome sequence of Human Parechovirus type 15. Sci Rep 2020;10:6759.
10.1038/s41598-020-63467-w32317760PMC7174385
22
Montmayeur AM, Ng TF, Schmidt A, Zhao K, Magaña L, Iber J, et al. High-Throughput Next-Generation Sequencing of Polioviruses. J Clin Microbiol 2017;55:606-15.
10.1128/JCM.02121-1627927929PMC5277531
23
Klenner J, Kohl C, Dabrowski PW, Nitsche A. Comparing Viral Metagenomic Extraction Methods. Curr Issues Mol Biol 2017;24:59-70.
10.21775/cimb.024.05928686568
24
Roth WK, Seifried E. Yield and future issues of nucleic acid testing. Transfus Clin Biol 2001;8:282-4.
10.1016/S1246-7820(01)00115-X
25
Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature 2020;579:265-9.
10.1038/s41586-020-2008-332015508PMC7094943
26
Wang C, Liu Z, Chen Z, Huang X, Xu M, He T, et al. The establishment of reference sequence for SARS-CoV-2 and variation analysis. J Med Virol 2020;92:667-74.
10.1002/jmv.2576232167180PMC7228400
27
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020;395:565-74.
10.1016/S0140-6736(20)30251-8
28
Kim JM, Chung YS, Jo HJ, Lee NJ, Kim MS, Woo SH, et al. Identification of Coronavirus Isolated from a Patient in Korea with COVID-19. Osong Public Health Res Perspect 2020;11:3-7.
10.24171/j.phrp.2020.11.1.0232149036PMC7045880
29
Roingeard P, Raynal PI, Eymieux S, Blanchard E. Virus detection by transmission electron microscopy: Still useful for diagnosis and a plus for biosafety. Rev Med Virol 2019;29:e2019.
10.1002/rmv.201930411832PMC7169071
30
Gullett JC, Nolte FS. Quantitative nucleic acid amplification methods for viral infections. Clin Chem 2015;61:72-8.
10.1373/clinchem.2014.22328925403817
31
Merckx J, Wali R, Schiller I, Caya C, Gore GC, Chartrand C, et al. Diagnostic Accuracy of Novel and Traditional Rapid Tests for Influenza Infection Compared With Reverse Transcriptase Polymerase Chain Reaction: A Systematic Review and Meta-analysis. Ann Intern Med 2017;167:394-409.
10.7326/M17-084828869986
32
Mahony JB, Petrich A, Smieja M. Molecular diagnosis of respiratory virus infections. Crit Rev Clin Lab Sci 2011;48:217-49.
10.3109/10408363.2011.64097622185616
33
Waters DL, Shapter FM. The polymerase chain reaction (PCR): general methods. Methods Mol Biol 2014;1099:65-75.
10.1007/978-1-62703-715-0_724243196
34
Lorenz TC. Polymerase chain reaction: basic protocol plus troubleshooting and optimization strategies. J Vis Exp 2012;22:e3998.
10.3791/399822664923PMC4846334
35
Rogers BB. The Evolution of the Polymerase Chain Reaction to Diagnose Childhood Infections. Pediatr Dev Pathol 2015;18:495-503.
10.2350/15-05-1643-OA.126701384
36
Richards GP. Limitations of molecular biological techniques for assessing the virological safety of foods. J Food Prot 1999;62:691-7.
10.4315/0362-028X-62.6.69110382664
37
Elnifro EM, Ashshi AM, Cooper RJ, Klapper PE. Multiplex PCR: optimization and application in diagnostic virology. Clin Microbiol Rev 2000;13:559-70.
10.1128/CMR.13.4.55911023957PMC88949
38
Bacich DJ, Sobek KM, Cummings JL, Atwood AA, O'Keefe DS. False negative results from using common PCR reagents. BMC Res Notes 2011;4:457.
10.1186/1756-0500-4-45722032271PMC3219698
39
Burkardt HJ. Standardization and quality control of PCR analyses. Clin Chem Lab Med 2000;38:87-91.
10.1515/CCLM.2000.01410834394
40
Sánchez-Seco MP, Rosario D, Hernández L, Domingo C, Valdés K, Guzmán MG, et al. Detection and subtyping of dengue 1-4 and yellow fever viruses by means of a multiplex RT-nested-PCR using degenerated primers. Trop Med Int Health 2006;11:1432-41.
10.1111/j.1365-3156.2006.01696.x16930266
41
Kim JY, Choe PG, Oh Y, Oh KJ, Kim J, Park SJ, et al. The First Case of 2019 Novel Coronavirus Pneumonia Imported into Korea from Wuhan, China: Implication for Infection Prevention and Control Measures. J Korean Med Sci 2020;35:e61.
10.3346/jkms.2020.35.e6132030925PMC7008073
42
van Kasteren PB, van der Veer B, van den Brink S, Wijsman L, de Jonge J, van den Brandt A, et al. Comparison of seven commercial RT-PCR diagnostic kits for COVID-19. J Clin Virol 2020;128:104412.
10.1016/j.jcv.2020.10441232416600PMC7206434
43
Vogels CBF, Brito AF, Wyllie AL, Fauver JR, Ott IM, Kalinich CC, et al. Analytical sensitivity and efficiency comparisons of SARS-COV-2 qRT-PCR primer-probe sets. medRxiv 2020.
44
Holland PM, Abramson RD, Watson R, Gelfand DH. Detection of specific polymerase chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci U S A 1991;88:7276-80.
10.1073/pnas.88.16.72761871133PMC52277
45
Manganelli R, Tyagi S, Smith I. Real Time PCR Using Molecular Beacons: A New Tool to Identify Point Mutations and to Analyze Gene Expression in Mycobacterium tuberculosis. Methods Mol Med 2001;54:295-310.
10.1385/1-59259-147-7:29521341083
46
Ponchel F, Toomes C, Bransfield K, Leong FT, Douglas SH, Field SL, et al. Real-time PCR based on SYBR-Green I fluorescence: An alternative to the TaqMan assay for a relative quantification of gene rearrangements, gene amplifications and micro gene deletions. BMC Biotechnol 2003;3:18.
10.1186/1472-6750-3-1814552656PMC270040
47
Korea Centers for Disease Control and Prevention (KCDC). Approval for emergency use of test reagent for COVID-19 gene detection (2020). https://www.cdc.go.kr/board/board.es?mid=a20505000000&bid=0017
48
Carlson CS, Emerson RO, Sherwood AM, Desmarais C, Chung MW, Parsons JM, et al. Using synthetic templates to design an unbiased multiplex PCR assay. Nat Commun 2013;4:2680.
10.1038/ncomms368024157944
49
Jung S, Kim J, Lee DJ, Oh EH, Lim H, Kim KP, et al. Extensible Multiplex Real-time PCR of MicroRNA Using Microparticles. Sci Rep 2016;6:22975.
10.1038/srep2297526964639PMC4786821
50
Houldcroft CJ, Beale MA, Breuer J. Clinical and biological insights from viral genome sequencing. Nat Rev Microbiol 2017;15:183-92.
10.1038/nrmicro.2016.18228090077PMC7097211
51
Kim JH, Kang M, Park E, Chung DR, Kim J, Hwang ES. A Simple and Multiplex Loop-Mediated Isothermal Amplification (LAMP) Assay for Rapid Detection of SARS-CoV. Biochip J 2019;13:341-51.
10.1007/s13206-019-3404-332226589PMC7097549
52
Li C, Ren L. Recent progress on the diagnosis of 2019 Novel Coronavirus. Transbound Emerg Dis 2020:10.
10.1111/tbed.1362032395897PMC7272792
53
Yan C, Cui J, Huang L, Du B, Chen L, Xue G, et al. Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay. Clin Microbiol Infect 2020;26:773-9.
10.1016/j.cmi.2020.04.00132276116PMC7144850
54
Xiang X, Qian K, Zhang Z, Lin F, Xie Y, Liu Y, et al. CRISPR-Cas Systems Based Molecular Diagnostic Tool for Infectious Diseases and Emerging 2019 Novel Coronavirus (COVID-19) Pneumonia. J Drug Target 2020:1-5.
10.1080/1061186X.2020.176963732401064PMC7265108
55
Chen JS, Ma E, Harrington LB, Da Costa M, Tian X, Palefsky JM, et al. CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity. Science 2018;360:436-9.
10.1126/science.aar624529449511PMC6628903
56
Broughton JP, Deng X, Yu G, Fasching CL, Servellita V, Singh J, et al. CRISPR-Cas12-based detection of SARS-CoV-2. Nat Biotechnol 2020.
10.1038/s41587-020-0513-432300245
57
Kim D, Lee JY, Yang JS, Kim JW, Kim VN, Chang H. The Architecture of SARS-CoV-2 Transcriptome. Cell 2020;181:914-21.
10.1016/j.cell.2020.04.01132330414PMC7179501
58
Fauver JR, Petrone ME, Hodcroft EB, Shioda K, Ehrlich HY, Watts AG, et al. Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States Cell 2020;181:990-6.
10.1016/j.cell.2020.04.02132386545PMC7204677
59
Lu J, du Plessis L, Liu Z, Hill V, Kang M, Lin H, et al. Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell 2020;181:997-1003.
10.1016/j.cell.2020.04.02332359424PMC7192124
60
Ward AB, Wilson IA. Innovations in structure-based antigen design and immune monitoring for next generation vaccines. Curr Opin Immunol 2020;65:50-6.
10.1016/j.coi.2020.03.01332387642PMC7174181
61
Wang LF, Anderson DE, Mackenzie JS, Merson MH. From Hendra to Wuhan: what has been learned in responding to emerging zoonotic viruses. Lancet 2020;395:e33-4.
10.1016/S0140-6736(20)30350-0
62
Schobel SA, Stucker KM, Moore ML, Anderson LJ, Larkin EK, Shankar J, et al. Respiratory Syncytial Virus whole-genome sequencing identifies convergent evolution of sequence duplication in the C-terminus of the G gene. Sci Rep 2016;6:26311.
10.1038/srep2631127212633PMC4876326
63
Peserico A, Marcacci M, Malatesta D, Di Domenico M, Pratelli A, Mangone I, et al. Diagnosis and characterization of canine distemper virus through sequencing by MinION nanopore technology. Sci Rep 2019;9:1714.
10.1038/s41598-018-37497-430737428PMC6368598
64
Lu H, Giordano F, Ning Z. Oxford Nanopore MinION Sequencing and Genome Assembly. Genomics Proteomics Bioinformatics 2016;14:265-79.
10.1016/j.gpb.2016.05.00427646134PMC5093776
Information
  • Publisher :The Korean Society for Microbiology and The Korean Society of Virology
  • Publisher(Ko) :대한미생물학회‧대한바이러스학회
  • Journal Title :JOURNAL OF BACTERIOLOGY AND VIROLOGY
  • Volume : 50
  • No :2
  • Pages :65-75
  • Received Date : 2020-05-26
  • Revised Date : 2020-06-21
  • Accepted Date : 2020-06-23
  • DOI :https://doi.org/10.4167/jbv.2020.50.2.065
Journal Informaiton JOURNAL OF BACTERIOLOGY AND VIROLOGY JOURNAL OF BACTERIOLOGY AND VIROLOGY
  • NRF
  • 임플란트학회 전용 배너
  • KOFST
  • crossref crossmark
  • crossref cited-by
  • crossref funder-registry
  • crosscheck
  • orcid
  • open access
  • ccl
Journal Informaiton Journal Informaiton - close